Showing results (81-90 of 235) with videos related to
Sort By:
Pageof 24
Clinical Pharmacokinetics|December 20, 2014
Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIVRajith K R Rajoli, David J Back, Steve Rannard, et al.Clinical Pharmacology and Therapeutics|May 7, 2003
Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitorsCarla B Washington, Charles Flexner, Lewis B Sheiner, et al.AIDS (London, England)|May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?Marco Vitoria, Andrew Hill, Nathan Ford, et al.Journal of Genetics|December 28, 2013
Effective population size and evolutionary dynamics in outbred laboratory populations of DrosophilaLaurence D Mueller, Amitabh Joshi, Marta Santos, et al.Experimental Gerontology|June 23, 2006
Do longevity mutants always show trade-offs?Wayne A Van Voorhies, James W Curtsinger, Michael R RoseEvolution; International Journal of Organic Evolution|June 2, 2017
COMPLEX TRADE-OFFS AND THE EVOLUTION OF STARVATION RESISTANCE IN DROSOPHILA MELANOGASTERAdam K Chippindale, Terence J F Chu, Michael R RoseRejuvenation Research|January 12, 2012
Paradoxical physiological transitions from aging to late life in DrosophilaParvin Shahrestani, Julie Quach, Laurence D Mueller, et al.The International Journal on Drug Policy|January 6, 2024
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19Victor Roy, Michele Buonora, Caty Simon, et al.American Journal of Physiology. Cell Physiology|April 13, 2004
Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signalingPaul A Rufo, Patricia W Lin, Adriana Andrade, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2010
Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211)Keith W Crawford, Chonghua Li, Anther Keung, et al.Pageof 24